Literature DB >> 34981495

Resveratrol as a Probable Multiheaded Treatment Approach for COVID-19.

Roohollah Ahmadian1,2, Hossein Biganeh1,2, Yunes Panahi3, Paul C Guest4, Tannaz Jamialahmadi5,6, Amirhossein Sahebkar7,8,9.   

Abstract

The COVID-19 pandemic has plagued the world for more than 1 year now and has resulted in over 77 million cases and 1.7 million related deaths. While we await the rollout of the vaccines, new treatments are urgently needed to reduce the effects of this devastating virus. Here, we describe a number of preclinical studies which show promising effects of the polyphenol resveratrol.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  COVID-19; Herbal medicine; Resveratrol

Mesh:

Substances:

Year:  2021        PMID: 34981495     DOI: 10.1007/978-3-030-73234-9_29

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

1.  Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors.

Authors:  A Ranjbar; M Jamshidi; S Torabi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-07       Impact factor: 3.507

  1 in total
  1 in total

Review 1.  The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection.

Authors:  Chih-Yun Yang; Yu-Hsuan Chen; Pei-Jung Liu; Wan-Chung Hu; Kuo-Cheng Lu; Kuo-Wang Tsai
Journal:  Int J Med Sci       Date:  2022-07-18       Impact factor: 3.642

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.